Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regional lymph node classification for lung cancer staging

C F Mountain1, C M Dresler

  • 1Division of Cardiothoracic Surgery, The University of California Medical Center at San Diego, USA.

Chest
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Home and workplace smoking bans in Italy, Ireland, Sweden, France and the Czech Republic.

The European respiratory journal·2009
Same author

Metabolic gene polymorphism frequencies in control populations.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Smoking, smoking cessation and the oncologist.

Lung cancer (Amsterdam, Netherlands)·2001
Same author

Gender differences in genetic susceptibility for lung cancer.

Lung cancer (Amsterdam, Netherlands)·2001
Same author

Tumor staging and classification in lung cancer. Summary of the international symposium. Madrid, Spain, 3-4 December 1999.

Lung cancer (Amsterdam, Netherlands)·2000
Same author

CT depiction of regional nodal stations for lung cancer staging.

AJR. American journal of roentgenology·2000
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
Same journal

Eisenmenger Syndrome: The Pulmonology Perspective.

Chest·2026
See all related articles

This study unifies lung cancer staging by standardizing lymph node station classification. The new system ensures consistent mapping for accurate clinical and surgical staging, improving patient care.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Imaging

Background:

  • Existing lung cancer staging systems for regional lymph nodes had inconsistencies.
  • Two primary classification schemas were in common use: the American Joint Committee on Cancer (AJCC) and the American Thoracic Society/North American Lung Cancer Study Group.
  • The need for a unified system to improve accuracy and reproducibility in lung cancer staging was recognized.

Purpose of the Study:

  • To unify the existing, disparate lymph node station classification systems for lung cancer staging.
  • To establish a single, standardized system for mapping lymph node stations in lung cancer.
  • To ensure compatibility with the international staging system for lung cancer.

Main Methods:

  • Designation of anatomic landmarks for 14 specific lymph node stations.

Related Experiment Videos

  • Integration of hilar, intrapulmonary, and mediastinal lymph node regions.
  • Development of a unified classification schema based on prior AJCC and ATS/NLCSG systems.

    • Main Results:

    • A unified classification system for 14 regional lymph node stations in lung cancer has been established.
    • The new system provides clear anatomic landmarks for consistent lymph node mapping.
    • The classification is compatible with the international staging system for lung cancer.

    Conclusions:

    • The unified lymph node station classification promotes consistent and reproducible staging for lung cancer.
    • This standardized approach is applicable for both clinical and surgical-pathologic staging.
    • The new system facilitates improved accuracy in lung cancer diagnosis and treatment planning.